Predicting desipramine levels in children and adolescents: A naturalistic clinical study

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 36, Issue 3, 1997, Pages 384-389

  Biederman, Joseph ^a   Faraone, Stephen V ^b   Baldessarini, Ross J ^b   Flood, James ^b   Meyer, Michele ^b   Wilens, Timothy ^b   Spencer, Thomas ^b   Chen, Lisa ^b   Weber, Wendy ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

clinical prediction; desipramine; pharmacokinetics

Indexed keywords

DESIPRAMINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG SAFETY; DRUG THERAPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; PREDICTION; PRIORITY JOURNAL;

EID: 0031025366     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004583-199703000-00017     Document Type: Article

References (22)

1. Alexanderson B, Sjoqvist F (1971), Individual differences in the pharmacokinetics of monomethylated tricyclic antidepressants: role of genetic and environmental factors and clinical importance. Ann N Y Acad Sci 179:739-751
2. Baldessarini RJ (1996), Drugs and the treatment of psychiatric disorders: antimanic and antidepressant agents. In: Goodman and Gilman's The Pharmacologic Basis of Therapeutics, Harden W, Rudin W, Molinoff PB, Rall T, eds. New York: McGraw-Hill, pp 431-459
3. Biederman J (1991a), Psychopharmacology in children and adolescents. In: Comprehensive Textbook of Child and Adolescent Psychiatry, Wiener J, ed. Washington, DC: American Psychiatric Press, pp 545-570
4. Biederman J (1991b), Sudden death in children treated with a tricyclic antidepressant: a commentary. J Am Acad Child Adolesc Psychiatry 30:495-497
5. Biederman J, Baldessarini RJ, Wright V, Knee D, Harmatz J (1989a), A double-blind placebo controlled study of desipramine in the treatment of attention deficit disorder: I. Efficacy. J Am Acad Child Adolesc Psychiatry 28:777-784
6. Biederman J, Baldessarini RJ, Wright V, Knee D, Harmatz J, Goldblatt A (1989b), A double-blind placebo controlled study of desipramine in the treatment of attention deficit disorder: II. Serum drug levels and cardiovascular findings. J Am Acad Child Adolesc Psychiatry 28:903-911
7. Geller B, Cooper TB, Schluchter MD, Warham JE, Carr LG (1987), Child and adolescent nortriptyline single dose pharmacokinetic parameters: Final report. J Clin Psychopharmacol 7:321-323
8. Hayes TA, Panitch ML, Barker E (1975), Imipramine dosage in children: a comment on imipramine and electrocardiographic abnormalities in hyperactive children. Am J Psychiatry 132:545-547
9. Jatlow PI (1987), Psychotropic drug disposition during development. In: Psychiatric Pharmacosciences of Children and Adolescents, Popper C, ed. Washington, DC: American Psychiatric Press, pp 27-44
10. Nelson JC, Jatlow PI (1987), Nonlinear desipramine kinetics: prevalence and importance. Clin Pharmacol Ther 41:666-670
11. Preskorn SH, Weller EB, Weller RA (1982), Depression in children: relationship between plasma imipramine levels and response. J Clin Psychiatry 43:450-453
12. Preskorn SH, Weller EB, Weller RA, Glotzbach E (1983), Plasma levels of imipramine and adverse effects in children. Am J Psychiatry 140: 1332-1335
13. Puig-Antich J, Perel JM, Lupatkin W et al. (1979), Plasma levels of imipramine (IMI) and desmethylimipramine (DMI) and clinical response in prepubertal major depressive disorder. J Am Acad Child Psychiatry 18:616-627
14. Puig-Antich J, Perel JM, Lupatkin W et al. (1987), Imipramine in prepubertal major depressive disorders. Arch Gen Psychiatry 44:81-89
15. Rudorfer MV, Potter WZ (1987), Pharmacokinetics of antidepressants. In: Psychopharmacology: The Third Generation of Progress, Meltzer HY, ed. New York: Raven Press, pp 1353-1363
16. Saraf KR, Klein DF, Gittelman-Klein R, Gootman N, Greenhill P (1978), EKG effects of imipramine treatment in children. J Am Acad Child Psychiatry 17:60-69
17. SAS Institute (1989), SAS/STAT User's Guide, Version 6. Cary, NC: SAS Institute
18. Teicher MH, Baldessarini RJ (1987), Developmental pharmacodynamics. In: Psychiatric Pharmacosciences of Children and Adolescents, Popper C, ed. Washington, DC: American Psychiatric Press, pp 47-80
19. Weissman MM, Jarrett RB, Rush JA (1987), Psychotherapy and its relevance to the pharmacotherapy of major depression: a decade later (1976-1985). In: Psychopharmacology: The Third Generation of Progress, Meltzer HY, ed. New York: Raven Press, pp 1059-1069
20. Weller EB, Weller RA, Preskorn SH, Glotzbach R (1982), Steady-state plasma imipramine levels in prepubertal depressed children. Am J Psychiatry 139:506-508
21. Wilens TE, Biederman J, Baldessarini RJ, Puopolo PR, Flood JG (1992), Developmental changes in serum concentrations of desipramine and 2-hydroxydesipramine during treatment with desipramine. J Am Acad Child Adolesc Psychiatry 31:691-698
22. Wilens TE, Biederman J, Spencer T, Geist DE (1993), A retrospective study of serum levels and electrocardiographic effects of nortriptyline in children and adolescents. J Am Acad Child Adolesc Psychiatry 32:270-277